Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation. [electronic resource]
Producer: 19990222Description: 107-14 p. digitalISSN:- 0360-3016
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Brain Neoplasms -- immunology
- Carcinoma, Non-Small-Cell Lung -- immunology
- Combined Modality Therapy
- Docetaxel
- Dose Fractionation, Radiation
- Drug Administration Schedule
- Feasibility Studies
- Female
- Glioblastoma -- immunology
- Humans
- Lung Neoplasms -- immunology
- Lymphocytes -- drug effects
- Lymphopenia -- etiology
- Male
- Middle Aged
- Neoplasms -- immunology
- Neutropenia -- etiology
- Paclitaxel -- administration & dosage
- Pelvic Neoplasms -- immunology
- Radiation-Sensitizing Agents -- administration & dosage
- Radiotherapy -- adverse effects
- Survival Analysis
- Taxoids
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.